ID23915A - Komposisi farmasi yang larut dengan cepat - Google Patents

Komposisi farmasi yang larut dengan cepat

Info

Publication number
ID23915A
ID23915A IDW20000676A ID20000676A ID23915A ID 23915 A ID23915 A ID 23915A ID W20000676 A IDW20000676 A ID W20000676A ID 20000676 A ID20000676 A ID 20000676A ID 23915 A ID23915 A ID 23915A
Authority
ID
Indonesia
Prior art keywords
quickly
pharmacy composition
pharmaceutical composition
composition
pharmacy
Prior art date
Application number
IDW20000676A
Other languages
English (en)
Indonesian (id)
Inventor
Mamoru Osashi
Kazuyoshi Ogasawara
Yoshimi Shirai
Hiroshi Fujioka
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of ID23915A publication Critical patent/ID23915A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/499Spiro-condensed pyrazines or piperazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
IDW20000676A 1997-10-20 1998-10-15 Komposisi farmasi yang larut dengan cepat ID23915A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30663597 1997-10-20

Publications (1)

Publication Number Publication Date
ID23915A true ID23915A (id) 2000-05-25

Family

ID=17959478

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000676A ID23915A (id) 1997-10-20 1998-10-15 Komposisi farmasi yang larut dengan cepat

Country Status (22)

Country Link
US (2) US7141249B2 (hu)
EP (1) EP1033132B1 (hu)
KR (1) KR100571614B1 (hu)
CN (1) CN1156277C (hu)
AT (1) ATE296101T1 (hu)
AU (1) AU740299B2 (hu)
BR (1) BR9814090A (hu)
CA (1) CA2306883C (hu)
CZ (1) CZ299018B6 (hu)
DE (1) DE69830333T2 (hu)
ES (1) ES2242298T3 (hu)
HK (1) HK1030359A1 (hu)
HU (1) HUP0004132A3 (hu)
ID (1) ID23915A (hu)
NO (1) NO319049B1 (hu)
NZ (1) NZ503796A (hu)
PL (1) PL191533B1 (hu)
PT (1) PT1033132E (hu)
RU (1) RU2203665C2 (hu)
TR (1) TR200001056T2 (hu)
TW (1) TW592728B (hu)
WO (1) WO1999020277A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU740299B2 (en) * 1997-10-20 2001-11-01 Dainippon Sumitomo Pharma Co., Ltd. Fast-dissolving pharmaceutical composition
DK1884242T3 (da) 2005-05-26 2013-05-06 Dainippon Sumitomo Pharma Co Farmaceutisk sammensætning omfattende lurasidon
EP2327406A4 (en) 2008-08-14 2014-04-09 Kyorin Seiyaku Kk STABILIZED PHARMACEUTICAL COMPOSITION
CN105769809A (zh) * 2014-12-23 2016-07-20 上海星泰医药科技有限公司 提高生物利用度的雷尼司他及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK607188A (da) * 1987-11-02 1989-06-22 Merck & Co Inc Tablet indeholdende en phthalazineddikesyreforbindelse
TW202450B (hu) 1991-06-26 1993-03-21 Dainippon Pharmaceutical Co
JPH0518672A (ja) * 1991-07-09 1993-01-26 Daido Steel Co Ltd 熱処理炉の冷却域における炉体構造
DE4141351A1 (de) * 1991-12-14 1993-06-17 Basf Ag Stabile pulverfoermige vitamin- und/oder carotinoid-praeparate und verfahren zu deren herstellung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
AU740299B2 (en) * 1997-10-20 2001-11-01 Dainippon Sumitomo Pharma Co., Ltd. Fast-dissolving pharmaceutical composition
DK1038525T3 (da) * 1997-10-20 2004-08-02 Dainippon Pharmaceutical Co Stabiliseret farmaceutisk præparat af tetrahydropyrrolo[1,2-a]pyrazin-4-spiro-3'-pyrrolidin

Also Published As

Publication number Publication date
CN1282246A (zh) 2001-01-31
DE69830333T2 (de) 2006-01-26
PL191533B1 (pl) 2006-06-30
US20020197308A1 (en) 2002-12-26
ES2242298T3 (es) 2005-11-01
DE69830333D1 (de) 2005-06-30
NO20002049L (no) 2000-06-19
CA2306883C (en) 2007-11-27
BR9814090A (pt) 2000-10-03
KR20010015781A (ko) 2001-02-26
RU2203665C2 (ru) 2003-05-10
AU9461998A (en) 1999-05-10
NZ503796A (en) 2001-11-30
PT1033132E (pt) 2005-09-30
AU740299B2 (en) 2001-11-01
EP1033132A1 (en) 2000-09-06
PL340045A1 (en) 2001-01-15
EP1033132B1 (en) 2005-05-25
HUP0004132A3 (en) 2006-06-28
WO1999020277A1 (fr) 1999-04-29
NO20002049D0 (no) 2000-04-18
HUP0004132A2 (hu) 2001-08-28
TW592728B (en) 2004-06-21
ATE296101T1 (de) 2005-06-15
CZ299018B6 (cs) 2008-04-02
NO319049B1 (no) 2005-06-06
EP1033132A8 (en) 2001-04-04
CZ20001418A3 (cs) 2000-10-11
US7141249B2 (en) 2006-11-28
US20060269599A1 (en) 2006-11-30
CA2306883A1 (en) 1999-04-29
CN1156277C (zh) 2004-07-07
TR200001056T2 (tr) 2000-09-21
HK1030359A1 (en) 2001-05-04
KR100571614B1 (ko) 2006-04-17

Similar Documents

Publication Publication Date Title
WO2003037864A1 (fr) Compose indolique, et utilisation a des fins therapeutiques
HK1049788A1 (en) Novel composition based on a thiazolidinedione andmetformin and use.
EP0992239A4 (en) NEUROPEPTIDE Y RECEPTOR ANTAGONIST
CA2260337A1 (en) Therapeutic agents
PL360294A1 (en) Propane-1,3-dione derivatives
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
SG77195A1 (en) Fungicidal 2-methoxybenzophenones
NO20002217D0 (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
CA2347195A1 (en) Oral pharmaceutical compositions containing buprenorphin
ITFI930030A0 (it) Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizione farmaceutiche che li contengo-no.
CA2386813A1 (en) Bicyclic imidazo-3-yl amine derivatives substituted on the 6-membered ring
ECSP045162A (es) "composiciones farmaceuticas a base de derivados de azetidina"
EP1379508A4 (en) N- (ARYL) -2-ARYLETHESULFONAMIDES AND THEIR THERAPEUTIC APPLICATIONS
WO2004000793A3 (en) Aminoacetonitrile derivatives suitable for controlling parasites
WO2003097585A3 (en) Amidoacetonitrile compounds
ID23915A (id) Komposisi farmasi yang larut dengan cepat
IT1308195B1 (it) Utensile per la troncatura di arbusti.
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
EP1008345A4 (en) ANTI-ALLERGIC AGENTS
DK0896822T3 (da) 4-aminopyrrol (3,2-d) pyrimidiner som neuropeptide Y receptorantagonister
ATE166229T1 (de) Antitussivum
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
NO20034529D0 (no) 3,7-diazabicyklo(3,3,1) formuleringer samt antiarytmiforbindelser
EP1132087A4 (en) MEDICINE AGAINST POLYCYSTIC OVARY SYNDROME
CA2290557A1 (en) Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1